Menu
View Cart  

Recommended Products

Visit Store
Gmp-inspection-preparation-checklist-130x160

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological-risk-eval-and-mngmnt-for-md-130x160

Biological Risk Evaluation and Management for Medical Devices

Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.

Events

View All
Jan 29

Developing Pharmaceutical Investigational Brochures & Annual Reports: Secrets to Practical Succes...

Jan 30

Regulating Software Used by Life Science Manufacturers: Is it a Medical Device or Not?

Feb 13

Building a World-Class Drug Supply Chain: Tips for Compliance and Digital Transformation

Feb 19

Medical Device Risk Management: Prepare for the Winds of Change

Mar 20

Medical Device Complaint Management: Escape the Labyrinth

Mar 26

Conducting Advanced Root Cause Analysis and CAPA Investigations

Editor's Picks

View all
Red_approved_stamp

Biom’up’s Laparoscopic Applicator Earns New Marketing Approval

The device quickly delivers Hemoblast powder to bleeding areas in minimally-invasive surgeries.
Handshake

Lawmakers Want Probe of BMS/Celgene Deal

The cancer drugs the company will acquire as part of the deal include Celgene’s blockbuster drug Revlimid.

AETERNA ZENTARIS PRESENTED POSITIVE IN VIVO DATA ON ZEN-019, AN ORAL, LHRH ANTAGONIST PEPTIDOMIMETIC

KEYWORDS Daily International Pharma Alert
A A

AEterna Zentaris Inc. today announced that it presented Abstract No. P3-257 during a poster presentation entitled "ZEN-019, A Peptidomimetic from a New Class of Orally Active GnRH (LHRH) Antagonists," on Monday, June 26, 2006 in the Exhibit Hall of the Boston Convention & Exhibition Center in Boston, Massachusetts, during the 2006 Annual Meeting of the Endocrine Society.

Drug Newswire (http://www.drugnewswire.com/2696/)